Phillip Scheinberg
12PUBLICATIONS
43CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (12)
Sort by Publication Date:
|Mar 19, 2026
Indirect treatment comparison of iptacopan versus pegcetacoplan for patients with paroxysmal nocturnal hemoglobinuria and residual anemia despite C5 inhibitor treatment.Austin Kulasekararaj, Phillip Scheinberg, Maria-Magdalena Balp
|Jun 14, 2025
Patient-reported outcomes in patients with paroxysmal nocturnal hemoglobinuria treated with crovalimab and approved C5 inhibitors in the phase III COMMODORE 2 and 1 studies.Jens Panse, Bing Han, Jaroslav Cermak
|Dec 02, 2024
Crovalimab in the paroxysmal nocturnal hemoglobinuria treatment landscape.Alexander Röth, Austin G Kulasekararaj, Phillip Scheinberg
|Jun 26, 2024
Phase 3 randomized COMMODORE 1 trial: Crovalimab versus eculizumab in complement inhibitor-experienced patients with paroxysmal nocturnal hemoglobinuria.Phillip Scheinberg, Diego Villa Clé, Jin Seok Kim
|Feb 01, 2023
Consensus proposal for revised International Working Group 2023 response criteria for higher-risk myelodysplastic syndromes.Amer M Zeidan, Uwe Platzbecker, Jan Philipp Bewersdorf
Pageof 2
Frequent Collaborators
5 joint publications
Austin Kulasekararaj
2 joint publications
Alexander Röth
2 joint publications
Jens Panse
1 joint publications
Régis Peffault de Latour
1 joint publications
Regis Goulart Rosa
1 joint publications
Flávia Ribeiro Machado
1 joint publications
Otávio Berwanger
1 joint publications
Renato Delascio Lopes
1 joint publications
Leticia Kawano-Dourado
1 joint publications
Viviane Cordeiro Veiga
